Multiple treatment and indirect treatment comparisons: An overview of network meta-analysis

Area of Science:

• Evidence-based medicine
• Biostatistics
• Clinical research methodology

Background:

• Randomized control trials (RCTs) and meta-analyses are gold standards in research evidence.
• Limitations exist in traditional meta-analyses, particularly for comparing multiple interventions simultaneously.
• Network meta-analysis (NMA) emerges as an advanced tool to address these limitations.

Purpose of the Study:

• To introduce and explain the methodology of network meta-analysis (NMA).
• To highlight the capability of NMA in comparing multiple treatment options, even without direct head-to-head trials.
• To discuss the underlying assumptions and statistical approaches used in NMA.

Main Methods:

• NMA integrates direct and indirect evidence from existing randomized control trials.
• It employs Bayesian or frequentist statistical frameworks, often utilizing software like WinBUGS.
• Assumptions of similarity and consistency are crucial for valid indirect treatment comparisons.

Main Results:

• NMA facilitates comparisons across multiple treatment options, expanding the scope beyond direct trial comparisons.
• The method synthesizes evidence to provide valuable insights for clinical decision-making.
• Statistical power and precision depend on factors like the number of trials and sample sizes.

Conclusions:

• Network meta-analysis (NMA) is a valuable extension of traditional meta-analysis for evidence-based medicine.
• It enables comprehensive comparisons of various treatments, informing healthcare professionals and policymakers.
• Further methodological refinements are anticipated to enhance the robustness of NMA.